The story of Viagra and its creator , copyright, presents a tangled picture for cautious investors. While the blockbuster drug initially fueled enormous profits , its exclusivity has expired , leading to generic alternatives flooding the arena. This reduction in pricing presents a real hurdle for copyright and any company considering a large stake